A Rare Opportunity To Turn $1,000 Into $1.57 Million

The Nobel Prize Committee is calling it "The Holy Grail of Medicine"

July 08, 2022 View in Browser / Unsubscribe Editor's Note: The message below from one of our partners is one we believe you should take a close look at. Dear Reader,   Super-investor Dylan Jovine may be the best takeover investor on earth. When he picks a takeover target, it often gets bought out in under 90 days. Loxo Oncology was taken over 3 days after he picked it for a 71% profit... Pacific Bio. was taken over 4 days after he picked it for a 72% gain... American Rail was taken over 58 days after he picked it for a 51% gain... Tesaro Inc was taken over 63 days after he picked it for a 91% profit... Today I have some great news for you! He just released his next Takeover Target. You can find out about it here>>> The tiny biotech he recommended just won a patent on a new kind of genetic software that can "Cut & Paste" any disease from your body. The Nobel Prize Committee is calling it "The Holy Grail of Medicine" The Wall Street Journal reports the company is "transforming medicine." 60 Minutes reports the company is "revolutionizing the search for new drugs." And Dylan says it reminds him of Array Biopharma, which was taken over by Pfizer on July 30, 2019, handing investors who followed his recommendation fast 148% profits. Learn the name of this company right now >>>   Sincerely, Simmy Adelman, Editor Behind the Markets   This email was sent to edwardlorilla1986.paxforex@blogger.com because you made a great decision to receive our newsletter.   Trading involves risk. The information provided is NOT trading advice. Neither the Editors, the Publisher, nor any of their respective affiliates make any guarantee or other promise as to any results that may be obtained from the newsletter. Past performance is no guarantee of future performance. This recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability for any purchase or order made from any company or entity mentioned or recommended in this email. The information provided is for educational purposes only. Please contact your financial advisor for specific financial advice tailored to your personal circumstances. Actual results may differ. Nothing here constitutes a recommendation respecting the particular security illustrated. Copyright © 2022 Leinster 134, London, SW35GB Property of Web Impact LLC. All Rights Reserved. Unsubscribe